BBRY stock has been one of the best performers of 2014, but don't buy the hype. If you believe the assets have value, buy the bonds instead. More
- ADVERTISEMENT
- ADVERTISEMENT
BBRY stock has been one of the best performers of 2014, but don't buy the hype. If you believe the assets have value, buy the bonds instead. More
Merck is one the most high profile companies in the pharmaceutical industry, and Merck stock is well worth a look for investors. I rate it a buy today. More
Every month brings new iPhone apps with it. Check out the 5 best new iPhone apps including the photo-editing app Faded and more. More
Bristol-Myers Squibb stock has a lot going for it, like the company's newfound focus on hepatitis C, oncology and immunotherapy. But BMY still might need time to reflect that potential. More
A recent study has discovered that legalizing weed may result in pot becoming more potent. The study found increased THC levels in areas where pot is legal. More
Xerox surprised shareholders with a nice bump up in its dividend, one of 13 dividend stocks that saw dividend increases during the week of January 20. More